Transforming Cancer Treatment
Through Targeted Innovation

The First Non-Surgical Therapy for Early-Stage Oral Cancer

100% of Patients Avoided Surgery
95.5% Complete Response Rate in Phase 2/3 Trial

Explore Our Science View Clinical Studies

Welcome to Privo Technologies

We strive to develop innovative therapeutics to eliminate cancers and prevent recurrence. We aim to provide better and more accessible treatment options to diverse patient populations around the world.

We fight every day because we know patients do too.

Our Focus Areas

Targeted Drug Delivery

Harnessing nanotechnology to encapsulate highly potent therapies and deliver them directly to the tumor site, enabling safer, more effective localized treatment.

Learn More →

Early Detection

Advancing clinical programs aligned with a core priority in oncology—early detection and early intervention to prevent disease progression while minimizing treatment-related morbidity.

Learn More →

Tough on Cancer. Easy on Patients

Designed to deliver the full therapeutic impact of chemotherapy at the tumor while limiting systemic exposure, reducing treatment burden, and helping patients maintain quality of life.

Learn More →